Andresa Heemann Betti
Overview
Explore the profile of Andresa Heemann Betti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
70
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferreira J, Flores V, Marco M, Fraga B, Zorzo R, de Morais P, et al.
Food Chem Toxicol
. 2024 Aug;
192:114962.
PMID: 39197520
Diazepam (DZP) is a sedative medication prescribed to treat anxiety and as a sleep inducer, although its residual effects are unfavorable to patients. Nanotechnology represents a tool to improve the...
2.
Kayser J, Petry F, Alijar Souza M, Santin Zanatta Schindler M, Vidor Morgan L, Zimmermann Prado Rodrigues G, et al.
Behav Pharmacol
. 2024 Jul;
35(6):338-350.
PMID: 39051900
Increasing evidence indicates that neuroinflammation, oxidative stress, and neurotrophic factors play a key role in the pathophysiology of major depressive disorder (MDD). In addition, the attenuation of inflammatory response has...
3.
Chiarentin R, Pereira Bottcher D, Zeni B, Grave C, Kaufmann F, Emmanoella Sebulsqui Saraiva T, et al.
Int J Pharm
. 2024 Jun;
660:124304.
PMID: 38848799
Depression is one of the most common psychiatric disorders. Nanotechnology has emerged to optimize the pharmacological response. Therefore, the aim of this work was to develop and characterize liposomes and...
4.
Betti A, Kenna J, Van Vleet T, Aruselvan P, Girardi Muller L
Front Pharmacol
. 2023 Aug;
14:1225806.
PMID: 37538182
No abstract available.
5.
Nodari C, De Quadros N, Chiarentin R, da Silva F, Morisso F, Charao M, et al.
Pharmacol Rep
. 2022 Sep;
74(5):969-981.
PMID: 36076124
Background: Vortioxetine hydrobromide (VXT), a new therapeutic option in the treatment of major depressive disorder, is a poorly soluble drug, and instability under stress conditions has been reported. The aim...
6.
Sabrina Anzollin G, Zaki L, Perin T, Finger B, Perin L, Petry F, et al.
J Tradit Complement Med
. 2022 Jun;
12(4):309-317.
PMID: 35747347
Background And Aim: Berg. (Myrtaceae) present several pharmacological actions, but there are no reports on its antidepressant-like potential. This study investigated the antidepressant-like effect and mechanism of action of seeds...
7.
Emmanoella Sebulsqui Saraiva T, Zimmermann Prado Rodrigues G, Kayser J, Dallegrave E, Maus N, Veiverberg A, et al.
Toxicol Mech Methods
. 2022 Apr;
32(9):705-715.
PMID: 35410575
Schizophrenia is a psychiatric disorder that affects 1% of the world population and is treated with antipsychotics, which may induce important biochemical and hematological alterations. Since it is necessary to...
8.
da Silva J, Dallegrave E, Zimmermann Prado Rodrigues G, Bigolin C, Neumann T, Schuster A, et al.
Drug Chem Toxicol
. 2020 Jun;
45(2):822-833.
PMID: 32552192
Meloxicam is the non-steroidal anti-inflammatory drug most used in small animals; however, studies on genotoxicity, oxidative stress, and histopathologic alterations in cardiac tissue are limited, especially at therapeutical doses used...
9.
Betti A, Antonio C, Herzfeldt V, da Rocha Pitta M, da Rocha Pitta I, do Rego J, et al.
Behav Pharmacol
. 2019 Jun;
30(7):574-587.
PMID: 31206371
Evidence of changes in central noradrenergic activity has been reported in schizophrenic patients and studies indicate that activation of the α2-adrenoceptor improves memory and neuroprotection. In this study, a new...
10.
Scapinello J, Girardi Muller L, Schindler M, Sabrina Anzollin G, Siebel A, Boligon A, et al.
J Ethnopharmacol
. 2019 Feb;
236:21-30.
PMID: 30802613
Materials And Methods: GC/MS and HPLC analysis were performed for EPB extract. We used EPB at 250, 375 and 500 mg/kg (oral route, p.o.) in male Swiss mice. The antinociceptive...